Cargando…

GPER Agonist G1 Prevents Wnt-Induced JUN Upregulation in HT29 Colorectal Cancer Cells

Women consistently show lower incidence and mortality rates for colorectal cancer (CRC) compared to men. Epidemiological evidence supports a pivotal role for estrogen in protecting women against CRC. Estrogen protective effects in CRC have been mainly attributed to the estrogen receptor beta (ERβ) h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abancens, Maria, Harvey, Brian J., McBryan, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603962/ https://www.ncbi.nlm.nih.gov/pubmed/36293473 http://dx.doi.org/10.3390/ijms232012581

Ejemplares similares

Sexual Dimorphism in Colon Cancer
por: Abancens, Maria, et al.
Publicado: (2020)

Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist
por: Ding, Qingming, et al.
Publicado: (2022)

GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions
por: Bustos, Viviana, et al.
Publicado: (2017)

Effects of the selective GPER1 agonist G1 on bone growth
por: Iravani, Maryam, et al.
Publicado: (2019)

Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma
por: Hirtz, Alex, et al.
Publicado: (2022)

Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells
por: Arriaga, Juan Martín, et al.
Publicado: (2017)

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
por: Chimento, Adele, et al.
Publicado: (2015)

GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation
por: Hirtz, Alex, et al.
Publicado: (2021)

The Effect of Avidin on Viability and Proliferation of Colorectal Cancer Cells HT-29
por: Dewi, Syarifah, et al.
Publicado: (2022)

Transcriptomic data of MCF-7 breast cancer cells treated with G1, a G-protein coupled estrogen receptor (GPER) agonist()
por: Pal, Uttariya, et al.
Publicado: (2022)

GPER agonist G1 suppresses neuronal apoptosis mediated by endoplasmic reticulum stress after cerebral ischemia/reperfusion injury
por: Han, Zi-Wei, et al.
Publicado: (2019)

The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells
por: Ambrosini, Grazia, et al.
Publicado: (2023)

G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells
por: Vo, Diep-Khanh Ho, et al.
Publicado: (2019)

Cathepsin B Is Upregulated and Mediates ECM Degradation in Colon Adenocarcinoma HT29 Cells Overexpressing Snail
por: Kryczka, Jakub, et al.
Publicado: (2019)

Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats
por: Jessup, Jewell A., et al.
Publicado: (2010)

Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells
por: Thangaraj, Kalaiyarasu, et al.
Publicado: (2019)

Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29
por: Lui, Yan Long Edmund, et al.
Publicado: (2013)

Effects of silencing neuropilin-2 on proliferation, migration, and invasion of colorectal cancer HT-29
por: Zhan, Qi-Qi, et al.
Publicado: (2022)

Metabolomic and Lipidomic Analysis of the Colorectal Adenocarcinoma Cell Line HT29 in Hypoxia and Reoxygenation
por: Barrera, Juan Carlos Alarcon, et al.
Publicado: (2023)

A Cell-Based Method to Detect Agonist and Antagonist Activities of Endocrine-Disrupting Chemicals on GPER
por: Périan, Séverine, et al.
Publicado: (2020)

Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
por: Kampa, Marilena, et al.
Publicado: (2023)

Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes
por: Sharma, Geetanjali, et al.
Publicado: (2021)

The G protein-coupled oestrogen receptor GPER in health and disease: an update
por: Prossnitz, Eric R., et al.
Publicado: (2023)

Sea Anemone Heteractis crispa Actinoporin Demonstrates In Vitro Anticancer Activities and Prevents HT-29 Colorectal Cancer Cell Migration
por: Kvetkina, Aleksandra, et al.
Publicado: (2020)

Effects of ICI 182,780, an ERα and ERβ antagonist, and G-1, a GPER agonist, on autophagy in breast cancer cells
por: Muler, Mari Luminosa, et al.
Publicado: (2020)

Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2021)

Oral 25-Hydroxycholecalciferol Acts as an Agonist in the Duodenum of Mice and as Modeled in Cultured Human HT-29 and Caco2 Cells
por: Reynolds, Carmen J, et al.
Publicado: (2020)

Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation
por: Molina, Luis, et al.
Publicado: (2020)

Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
por: Liu, Qiao, et al.
Publicado: (2017)

Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts
por: Carlin, Sean, et al.
Publicado: (2010)

Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells
por: Jackson, Kiren, et al.
Publicado: (2020)

Combination effects of capecitabine, irinotecan and 17-AAG on colorectal cancer cell line (HT-29)
por: Zeynali-Moghaddam, Shima, et al.
Publicado: (2022)

Assessment of Oxaliplatin-Loaded Iodine Nanoparticles for Chemoradiotherapy of Human Colorectal Cancer (HT-29) Cells
por: Rasouli, Naser, et al.
Publicado: (2022)

Anticancer properties of curcumin-treated Lactobacillus plantarum against the HT-29 colorectal adenocarcinoma cells
por: Gholipour, Faranak, et al.
Publicado: (2023)

Mucin Binding Protein of Lactobacillus casei Inhibits HT-29 Colorectal Cancer Cell Proliferation
por: Ju, Xuan, et al.
Publicado: (2023)

Combination of CNTs with Classical Drugs for Treatment in Human Colorectal Adenocarcinoma (HT-29) Cell Line
por: Abreu, Sara, et al.
Publicado: (2023)

Editorial: GPER and Human Pathologies
por: Jacquot, Yves, et al.
Publicado: (2021)

Editorial: GPER: Control and Functions
por: Jacquot, Yves, et al.
Publicado: (2021)

RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9
por: Xue, Jun, et al.
Publicado: (2020)

Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER
por: Gilligan, Lorna C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3so9dhau0oj5qjrntndajc29db